Role of cGAS-STING in Afterload-Induced Cardiac Remodeling
Role of cGAS-STING in Afterload-Induced Cardiac Remodeling
批准号:
10625953
负责人:
JOSEPH A HILL
金额:
$41.0万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-04-05 至 2028-03-31
关键词:
AbbreviationsAntigen PresentationAntigen-Presenting CellsApoptosisAtherosclerosisAtrial FibrillationCD27 AntigensCD28 geneCD80 geneCD86 geneCTLA4 geneCXCL9 geneCardiacCardiac MyocytesCardiovascular systemCell physiologyCellsClinicalClinical TrialsCollaborationsCore FacilityCyclic GMPCytosolCytotoxic T-LymphocytesDNADataDendritic CellsDevelopmentElementsEventExtracellular MatrixFailureFibroblastsFibrosisFunctional disorderGoalsGrowthHeartHeart DiseasesHeart HypertrophyHeart failureHomingHypertrophic CardiomyopathyHypertrophyImmuneImmune responseImmunomodulatorsImmunotherapyInflammatoryInterferonsInterventionKnowledgeKnowledge acquisitionLigandsMacrophageMalignant NeoplasmsMediatingMolecularMyocardial InfarctionMyocardial IschemiaPathway interactionsPatientsPatternPopulationProcessProductionReactionReadingReagentRegulationReportingResearch DesignRoleSTING agonistsSecond Messenger SystemsSeriesSignal TransductionStimulator of Interferon GenesStressT cell regulationT-Cell ActivationT-Cell ProliferationT-LymphocyteTCR ActivationTestingTranslationsUp-RegulationVentricular ArrhythmiaVentricular RemodelingWorkadaptive immune responseantagonistantimicrobialcancer complicationcancer immunotherapycell typecytotoxic CD8 T cellsds-DNAhypertensive heart diseaseinsightnovelpathogenpharmacologicpressureprogrammed cell death protein 1programsrecruitresponsesensortargeted treatmenttoolventricular hypertrophy
中文摘要
项目总结
英文摘要
PROJECT SUMMARY
Whereas it is long known that immune responses are pivotal to the heart’s reaction to stress, our understanding of
those events in myocardial remodeling occurring in response to afterload stress is limited. Recently, we reported a pivotal
role for cGAS-STING (cyclic GMP-AMP Synthase-Stimulator of Interferon Genes) in myocardial infarction. Going
forward, we uncovered evidence for a novel role of cGAS-STING in load-induced cardiac hypertrophy and failure. We
have discovered that loss of STING – surprisingly – exacerbated hypertrophy and fibrosis triggered by pressure stress.
We observed a marked increase in CD86, CD80, and CD28, signatures of T cell activation, and cytotoxic T cell
proliferation in STING-deficient hearts. In addition, CD103+ cells, representing the antigen presenting dendritic cell
population, are doubled in response to pressure overload in STING-deficient heart compared to WT. Furthermore, our
data reveal that STING is expressed in cardiac immune cells and fibroblasts, in contrast to cGAS, which is present
predominantly in macrophages. STING’s broader scope of distribution suggests a more prominent role in cardiac
hypertrophy. Based on this evidence, we propose studies focusing on STING to dissect the underlying molecular
circuitry. We hypothesize that STING regulates T cell activation and antigen presentation, adaptive immune processes
crucial to myocardial remodeling and development of heart failure, in the setting of afterload stress.
Here, we propose studies to define and manipulate STING-dependent regulation of T cell function in afterload stress-
induced cardiac remodeling, focusing on both ventricular hypertrophy and ultimate contractile dysfunction. With an eye
toward ultimate translation to patients with heart disease, we also capitalize on pharmacological tools, some of which are
currently being tested in clinical trials in cancer, to manipulate STING signaling.
The cGAS-STING pathway-mediated immune response, spanning both innate and adaptive elements, represents an
entirely novel mechanism of cardiac remodeling and failure. Furthermore, knowledge acquired during these studies is
likely to shed light on other forms of heart disease and elucidate cardiac complications of cancer immunotherapy.
We propose a comprehensive series of studies to define the role of cGAS-STING in afterload-induced cardiac
remodeling. These studies interlace at many points with work proposed in the 3 other Projects. We have developed
multiple points of bidirectional collaboration across the entire Program, sharing of reagents and insights, as well as benefit
from extensive use of the Core facilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
-
批准号:10471883
-
项目类别:
-
资助金额:$61.53万
-
财政年份:2020
-
负责人:JOSEPH A HILL
-
依托单位:
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
-
批准号:10681357
-
项目类别:
-
资助金额:$61.06万
-
财政年份:2020
-
负责人:JOSEPH A HILL
-
依托单位:
Cardiomyocyte bromodomain protein 4 (BRD4) in physiology and disease
-
批准号:10241315
-
项目类别:
-
资助金额:$61.98万
-
财政年份:2020
-
负责人:JOSEPH A HILL
-
依托单位:
Training in Cardiovascular Research
-
批准号:10454096
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2015
-
负责人:JOSEPH A HILL
-
依托单位:
Training in Cardiovascular Research
-
批准号:9301343
-
项目类别:
-
资助金额:$44.12万
-
财政年份:2015
-
负责人:JOSEPH A HILL
-
依托单位:
Training in Cardiovascular Research
-
批准号:10663074
-
项目类别:
-
资助金额:$54.23万
-
财政年份:2015
-
负责人:JOSEPH A HILL
-
依托单位:
Training in Cardiovascular Research
-
批准号:9033943
-
项目类别:
-
资助金额:$42.59万
-
财政年份:2015
-
负责人:JOSEPH A HILL
-
依托单位:
STIM1: Master Regulator of Calcium Homeostasis in Cardiomyocytes
-
批准号:8605448
-
项目类别:
-
资助金额:$37.84万
-
财政年份:2013
-
负责人:JOSEPH A HILL
-
依托单位:
STIM1: Master Regulator of Calcium Homeostasis in Cardiomyocytes
-
批准号:8722622
-
项目类别:
-
资助金额:$38.96万
-
财政年份:2013
-
负责人:JOSEPH A HILL
-
依托单位:
Foxo: Negative Regulator of Cardiac Hypertrophy
-
批准号:7806527
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
Functional Genomics of Complex Vascular Disease
-
批准号:7856276
-
项目类别:
-
资助金额:$68.82万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
Foxo: Negative Regulator of Cardiac Hypertrophy
-
批准号:8054881
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
Functional Genomics of Complex Vascular Disease
-
批准号:7940951
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
Foxo: Negative Regulator of Cardiac Hypertrophy
-
批准号:8250033
-
项目类别:
-
资助金额:$38.86万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
Foxo: Negative Regulator of Cardiac Hypertrophy
-
批准号:7655813
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
Rodent Ultrasound Imaging System
-
批准号:7595972
-
项目类别:
-
资助金额:$29.02万
-
财政年份:2009
-
负责人:JOSEPH A HILL
-
依托单位:
HDAC Inhibition in Cardiac Hypertrophy and Failure
-
批准号:7539918
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:JOSEPH A HILL
-
依托单位:
HDAC Inhibition in Cardiac Hypertrophy and Failure
-
批准号:7754052
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:JOSEPH A HILL
-
依托单位:
HDAC Inhibition in Cardiac Hypertrophy and Failure
-
批准号:7212787
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:JOSEPH A HILL
-
依托单位:
HDAC Inhibition in Cardiac Hypertrophy and Failure
-
批准号:7339830
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2007
-
负责人:JOSEPH A HILL
-
依托单位:
海外基金